|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMBRYONIC STEM CELLS |
-primed Endodermal Secretome
1 Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology & Experimental Therapeutics, and Medical Genetics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
* To whom correspondence should be addressed. E-mail: terzic.andre{at}mayo.edu.
| Abstract |
|---|
In the developing embryo, instructive guidance from the ventral endoderm secures cardiac program induction within the antero-lateral mesoderm. Endoderm-guided cardiogenesis, however, has yet to be resolved at the proteome level. Here, through cardiogenic priming of the endoderm with the reprogramming cytokine TNF
, candidate effectors of embryonic stem cell cardiac differentiation were delineated by comparative proteomics. Differential two-dimensional gel electrophoretic mapping revealed that over 75% of protein species increased >1.5-fold in the TNF
-primed versus unprimed endodermal secretome. Protein spot identification by linear ion trap quadrupole (LTQ) tandem mass spectrometry (MS/MS), and validation by shotgun LTQ-Fourier Transform MS/MS following multidimensional chromatography, mapped 99 unique proteins from 153 spot assignments. A definitive set of 48 secretome proteins was deduced by iterative bioinformatic screening using algorithms for detection of canonical and non-canonical indices of secretion. Protein-protein interaction analysis, in conjunction with respective expression level changes, revealed a non-stochastic TNF
-centric secretome network with a scale-free hierarchical architecture. Cardiovascular development was the primary developmental function of the resolved TNF
-anchored network. Functional cooperativity of the derived cardioinductive network was validated through direct application of the TNF
-primed secretome on embryonic stem cells, potentiating cardiac commitment and sarcomerogenesis. Conversely, inhibition of primary network hubs negated the pro-cardiogenic effects of TNF
priming. Thus, proteomic cartography establishes a systems biology framework for the endodermal secretome network guiding stem cell cardiac differentiation.
This article has been cited by other articles:
![]() |
S. Yamada, T. J. Nelson, R. J. Crespo-Diaz, C. Perez-Terzic, X.-K. Liu, T. Miki, S. Seino, A. Behfar, and A. Terzic Embryonic Stem Cell Therapy of Heart Failure in Genetic Cardiomyopathy Stem Cells, October 1, 2008; 26(10): 2644 - 2653. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Penn and A. A. Mangi Genetic Enhancement of Stem Cell Engraftment, Survival, and Efficacy Circ. Res., June 20, 2008; 102(12): 1471 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Nelson, R. S. Faustino, A. Chiriac, R. Crespo-Diaz, A. Behfar, and A. Terzic CXCR4+/FLK-1+ Biomarkers Select a Cardiopoietic Lineage from Embryonic Stem Cells Stem Cells, June 1, 2008; 26(6): 1464 - 1473. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |